BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25581585)

  • 21. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
    Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
    Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
    Roozeboom MH; Arits AHMM; Mosterd K; Sommer A; Essers BAB; de Rooij MJM; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
    J Invest Dermatol; 2016 Aug; 136(8):1568-1574. PubMed ID: 27113429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The choice and measurement of fluence in photodynamic therapy for superficial basal cell carcinoma.
    van der Beek N; Bjerring P; Neumann HA
    Br J Dermatol; 2015 Oct; 173(4):1105-6. PubMed ID: 26146762
    [No Abstract]   [Full Text] [Related]  

  • 24. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential treatment of giant basal cell carcinomas.
    Madan V; West CA; Murphy JV; Lear JT
    J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The choice and measurement of fluence in photodynamic therapy for superficial basal cell carcinoma: reply from the authors.
    Roozeboom MH; Arits AH; Kelleners-Smeets NW
    Br J Dermatol; 2015 Oct; 173(4):1106-7. PubMed ID: 26154079
    [No Abstract]   [Full Text] [Related]  

  • 27. Topical 5-aminolevulinic acid-mediated photodynamic therapy for basal cell carcinoma.
    Filonenko E; Kaprin A; Urlova A; Grigorievykh N; Ivanova-Radkevich V
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101644. PubMed ID: 32062047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy.
    Ghaffar SA; Clements SE; Lear JT
    Clin Exp Dermatol; 2007 Mar; 32(2):223-4. PubMed ID: 17137478
    [No Abstract]   [Full Text] [Related]  

  • 29. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
    Hürlimann AF; Hänggi G; Panizzon RG
    Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems associated with the use of broad-band illumination sources for photodynamic therapy.
    Stringer MR
    Phys Med Biol; 1995 Oct; 40(10):1733-5. PubMed ID: 8532752
    [No Abstract]   [Full Text] [Related]  

  • 31. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
    Essers BAB; Arits AH; Hendriks MR; Mosterd K; Kelleners-Smeets NW
    Br J Dermatol; 2018 Jan; 178(1):e26-e27. PubMed ID: 28667739
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study.
    LoPiccolo MC; Sage RJ; Kouba DJ
    Dermatol Surg; 2011 Jul; 37(7):1047-50. PubMed ID: 21388481
    [No Abstract]   [Full Text] [Related]  

  • 33. Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
    McGillis ST; Fein H
    Semin Cutan Med Surg; 2004 Sep; 23(3):174-83. PubMed ID: 15584683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
    Szeimies RM
    Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photodynamic therapy for basal cell carcinoma.
    Fargnoli MC; Peris K
    Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome.
    Chapas AM; Gilchrest BA
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):3-5. PubMed ID: 16485873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
    Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of choice in superficial basal cell carcinoma.
    de Haas ER
    Br J Dermatol; 2015 Mar; 172(3):563. PubMed ID: 25776243
    [No Abstract]   [Full Text] [Related]  

  • 39. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.